Summary

Electrophysiology Mapping And Ablation Devices Market Summary

The global electrophysiology mapping and ablation devices market size was estimated at USD 25.72 billion in 2024 and is projected to reach USD 62.61 billion by 2033, growing at a CAGR of 9.23% from 2025 to 2033. Growing adoption of electrophysiology (EP) mapping and ablation devices for the diagnosis and treatment of complex arrhythmias, particularly atrial fibrillation, is a key driver of market growth.

Rising demand for advanced rhythm management tools in both hospital and ambulatory settings, coupled with the increasing burden of cardiac conditions among younger populations due to sedentary lifestyles, smoking, and alcohol use, is accelerating device utilization. According to a February 2024 article by Johnson & Johnson Services, Inc., over 37.5 million people globally are affected by atrial fibrillation. Roughly 1 in 4 adults over 40 are projected to develop the condition during their lifetime. The increasing use of electrophysiology mapping and ablation devices for diagnosing and treating complex arrhythmias, especially atrial fibrillation, is a major growth catalyst for the market. These devices allow for highly precise localization of abnormal electrical pathways, improving procedural outcomes and reducing recurrence rates. As clinical guidelines continue to emphasize catheter ablation as a frontline therapy for symptomatic AF, adoption is gaining momentum among both high-volume centers and emerging EP programs worldwide. In March 2025, Abbott received CE Mark approval in Europe for its Volt Pulsed Field Ablation (PFA) System, enabling commercial use for atrial fibrillation treatment. The system integrates with Abbott’s EnSite X mapping platform and is designed to simplify workflows using a single catheter for mapping, pacing, and ablation.

The shift toward minimally invasive cardiac procedures in both hospital and ambulatory care environments is driving demand for advanced EP mapping and ablation tools. These devices are becoming integral to rhythm management workflows, offering real-time imaging and high-resolution data. In May 2025, a joint EHRA-HRS-ESC consensus in EP Europace urged improved standardization in AI-based electrophysiology research. The EHRA AI checklist showed that fewer than 55% of studies reported essential methods, with transparency in trial registration and model training below 20%, highlighting the need for more rigorous reporting practices. The statement aims to guide future AI applications toward greater clinical reliability and reproducibility.

Global Electrophysiology Mapping And Ablation Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. for this study, Grand View Research has segmented the global electrophysiology mapping and ablation devices market report based on procedure type, product coverage, and region:

• Procedure Type Outlook (Revenue, USD Thousand, 2021 - 2033)
• EP Ablation Procedures
o By Indication
o Atrial Fibrillation
o Paroxysmal AF
o Persistent AF
o Long standing persistent/permanent
o Right Atrial Flutter
o Left Atrial Flutter
o Atrioventricular Nodal Reentry Tachycardia (AVNRT)
o Right Atrial Tachycardia (AT)
o Left Atrial Tachycardia (AT)
o Right Wolff-Parkinson-White (WPW
o Left Wolff-Parkinson-White (WPW)
o Right Ventricular Tachycardia (VT)
o Left Ventricular Tachycardia (VT)
• Stand-Alone EP Diagnostic Procedures
o By Product Type
o Focal Ablation Catheter
o Radiofrequency (RF)
o Conventional
o Irrigated-tip
o Contact-Force-Sensing
o Standard
o Alternative Energy
o Pulsed Field Ablation
o Balloon Ablation Catheters
• Product Coverage Outlook (Revenue, USD Million, 2021 - 2033)
• Mapping & Lab Systems
o X-Ray Systems
o Mapping Systems
o EP Recording Systems
o ICE Systems
o RF Ablation Generators
o Pulsed Field Ablation Generators
o Cryoablation Generators
• Diagnostic Catheters
o Conventional
o Fixed
o Steerable
o Advanced
o Ultrasound
• Ablation Catheters
o Focal Ablation Catheter
o Radiofrequency (RF)
o Conventional
o Irrigated-tip
o Contact-Force-Sensing
o Standard
o Alternative Energy
o Pulsed Field Ablation
o Balloon Ablation Catheters
• Accessory Devices
o Long Introducer Sheaths
o Fixed
o Steerable
• Transseptal Needles
o Conventional
o RF
• Navigational Accessories
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o Japan
o China
o India
o South Korea
o Australia
o Thailand
• Latin America
o Brazil
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait 

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Procedure type outlook
2.2.2. Product coverage outlook
2.3. Competitive Insights
Chapter 3. Global Electrophysiology (EP) Mapping and Ablation Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Global Electrophysiology (EP) Mapping and Ablation Devices: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Technology Landscape
3.5. Case Study Analysis
Chapter 4. Global Electrophysiology (EP) Mapping and Ablation Devices Market Segment Analysis, By Procedure Type, 2021 - 2033 (USD Million)
4.1. Definition and Scope
4.2. Procedure Type Market Share Analysis, 2024 & 2033
4.3. Segment Dashboard
4.4. Global Electrophysiology (EP) Mapping and Ablation Devices Market, by Procedure Type, 2021 to 2033
4.5. EP Ablation Procedures
4.5.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.2. By Indication
4.5.3. Atrial Fibrillation
4.5.3.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.3.2. Paroxysmal AF
4.5.3.2.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.3.3. Persistent AF
4.5.3.3.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.3.4. Long standing persistent/permanent
4.5.3.4.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.4. Right Atrial Flutter
4.5.4.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.5. Left Atrial Flutter
4.5.5.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.6. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
4.5.6.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.7. Right Atrial Tachycardia (AT)
4.5.7.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.8. Left Atrial Tachycardia (AT)
4.5.8.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.9. Right Wolff-Parkinson-White (WPW)
4.5.9.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.10. Left Wolff-Parkinson-White (WPW)
4.5.10.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.11. Right Ventricular Tachycardia (VT)
4.5.11.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.12. Left Ventricular Tachycardia (VT)
4.5.12.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13. By Product Type
4.5.13.1. Focal ablation catheter
4.5.13.1.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13.1.2. Radiofrequency (RF)
4.5.13.1.2.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13.1.2.2. Conventional
4.5.13.1.2.2.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13.1.2.3. Irrigated-tip
4.5.13.1.2.3.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13.1.2.3.2. Contact-force-sensing
4.5.13.1.2.3.2.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13.1.2.3.3. Standard
4.5.13.1.2.3.3.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13.1.3. Alternative energy
4.5.13.1.3.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13.1.4. Pulsed field ablation
4.5.13.1.4.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.5.13.2. Balloon ablation catheters
4.5.13.2.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
4.6. Stand-Alone EP Diagnostic Procedures
4.6.1. Market estimates and forecast 2021 - 2033 (USD Thousand)
Chapter 5. Global Electrophysiology (EP) Mapping and Ablation Devices Market Segment Analysis, By Product Coverage, 2021 - 2033 (USD Million)
5.1. Definition and Scope
5.2. Product Coverage Market Share Analysis, 2024 & 2033
5.3. Segment Dashboard
5.4. Global Electrophysiology (EP) Mapping and Ablation Devices Market, by Product Coverage, 2021 to 2033
5.5. Mapping & Lab Systems
5.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.5.2. X-Ray Systems
5.5.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.5.3. Mapping Systems
5.5.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.5.4. EP Recording Systems
5.5.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.5.5. ICE Systems
5.5.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.5.6. RF Ablation Generators
5.5.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.5.7. Pulsed Field Ablation Generators
5.5.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.5.8. Cryoablation Generators
5.5.8.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.6. Diagnostic Catheters
5.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.6.2. Conventional
5.6.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.6.2.2. Fixed
5.6.2.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.6.2.3. Steerable
5.6.2.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.6.3. Advanced
5.6.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.6.4. Ultrasound
5.6.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7. Ablation Catheters
5.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2. Focal Ablation Catheter
5.7.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2.2. Radiofrequency (RF)
5.7.2.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2.2.2. Conventional
5.7.2.2.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2.2.3. Irrigated-tip
5.7.2.2.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2.2.3.2. Contact-force-sensing
5.7.2.2.3.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2.2.3.3. Standard
5.7.2.2.3.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2.3. Alternative energy
5.7.2.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.2.4. Pulsed field ablation
5.7.2.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.7.3. Balloon Ablation Catheters
5.7.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8. Accessory Devices
5.8.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8.2. Long Introducer Sheaths
5.8.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8.2.2. Fixed
5.8.2.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8.2.3. Steerable
5.8.2.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8.3. Transseptal Needles
5.8.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8.3.2. Conventional
5.8.3.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8.3.3. RF
5.8.3.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
5.8.4. Navigational Accessories
5.8.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
Chapter 6. Electrophysiology (EP) Mapping and Ablation Devices Market Segment Analysis, By Region, 2021 - 2033 (USD Million)
6.1. Regional Market Share Analysis, 2024 & 2034
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Electrophysiology (EP) Mapping and Ablation Devices Market Share by Region, 2024 & 2033
6.5. North America
6.5.1. North America electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.5.2. U.S.
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Scenario
6.5.2.3. Competitive Scenario
6.5.2.4. U.S. electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.5.3. Canada
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Scenario
6.5.3.3. Competitive Scenario
6.5.3.4. Canada electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Scenario
6.5.4.3. Competitive Scenario
6.5.4.4. Mexico electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6. Europe
6.6.1. Europe electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.2. UK
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Scenario
6.6.2.3. Competitive Scenario
6.6.2.4. UK electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.3. Germany
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Scenario
6.6.3.3. Competitive Scenario
6.6.3.4. Germany electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.4. France
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Scenario
6.6.4.3. Competitive Scenario
6.6.4.4. France electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.5. Italy
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Scenario
6.6.5.3. Competitive Scenario
6.6.5.4. Italy electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.6. Spain
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Scenario
6.6.6.3. Competitive Scenario
6.6.6.4. Spain electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.7. Norway
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Scenario
6.6.7.3. Competitive Scenario
6.6.7.4. Norway electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.8. Sweden
6.6.8.1. Key Country Dynamics
6.6.8.2. Regulatory Scenario
6.6.8.3. Competitive Scenario
6.6.8.4. Sweden electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.6.9. Denmark
6.6.9.1. Key Country Dynamics
6.6.9.2. Regulatory Scenario
6.6.9.3. Competitive Scenario
6.6.9.4. Denmark electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key Country Dynamics
6.7.1.2. Regulatory Scenario
6.7.1.3. Competitive Scenario
6.7.1.4. Japan electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.2. China
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Scenario
6.7.2.3. Competitive Scenario
6.7.2.4. China electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.3. India
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Scenario
6.7.3.3. Competitive Scenario
6.7.3.4. India electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.4. Australia
6.7.4.1. Key Country Dynamics
6.7.4.2. Regulatory Scenario
6.7.4.3. Competitive Scenario
6.7.4.4. Australia electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.5. South Korea
6.7.5.1. Key Country Dynamics
6.7.5.2. Regulatory Scenario
6.7.5.3. Competitive Scenario
6.7.5.4. South Korea electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.7.6. Thailand
6.7.6.1. Key Country Dynamics
6.7.6.2. Regulatory Scenario
6.7.6.3. Competitive Scenario
6.7.6.4. Thailand electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key Country Dynamics
6.8.1.2. Regulatory Scenario
6.8.1.3. Competitive Scenario
6.8.1.4. Brazil electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.8.2. Argentina
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Scenario
6.8.2.3. Competitive Scenario
6.8.2.4. Argentina electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key Country Dynamics
6.9.1.2. Regulatory Scenario
6.9.1.3. Competitive Scenario
6.9.1.4. South Africa electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key Country Dynamics
6.9.2.2. Regulatory Scenario
6.9.2.3. Competitive Scenario
6.9.2.4. Saudi Arabia electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.9.3. UAE
6.9.3.1. Key Country Dynamics
6.9.3.2. Regulatory Scenario
6.9.3.3. Competitive Scenario
6.9.3.4. UAE electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key Country Dynamics
6.9.4.2. Regulatory Scenario
6.9.4.3. Competitive Scenario
6.9.4.4. Kuwait electrophysiology (EP) mapping and ablation devices market, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization
7.3. Company Profiles
7.3.1. Siemens Healthineers
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Koninklijke Philips N.V.
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Abbott
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Johnson & Johnson (Biosense Webster)
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. GE HealthCare
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Boston Scientific Corporation
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Medtronic
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Biotronik SE & Co KG
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. MicroPort Scientific Corporation
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. CardioFocus, Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives